Diffusion (DFFN) is a biopharmaceutical company focused on the development of treatments that augment the effects seen from current standard of care cancer therapies. The company’s lead compound is ...

If you are looking to invest in Diffusion Pharmaceuticals Inc’s (NASDAQ:DFFN), or currently own the stock, then you need to understand its beta in order to understand how it can affect the risk of ...

Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios. In fact, most people expect hedge funds to compete with and ...

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...

Trailing twelve-month data shows us that Diffusion Pharmaceuticals Inc.'s (NASDAQ:DFFN) earnings loss has accumulated to -US$17.5m. Although some investors expected this, their belief in the path to ...

If you own shares in Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) then it’s worth thinking about how it contributes to the volatility of your portfolio, overall. In finance, Beta is a measure of ...

In November 2021, Diffusion Pharmaceuticals, Inc. (NASDAQ:DFFN) announced that the company is intending to develop its lead drug candidate, trans sodium crocetinate (TSC), for the treatment of hypoxic ...

NEW YORK, April 3, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches ...

On June 30, 2021, Diffusion Pharmaceuticals, Inc. DFFN announced topline results from the Phase 1 transcutaneous oxygen monitoring (TCOM) study of its lead development product trans sodium crocetinate ...

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! It's not possible to invest over long periods without making some bad ...

*The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. It is possible that this date will be updated in the future, once the company announces the ...